Literature DB >> 25366297

Prostate cancer: copper unlocks therapeutic potential of disulfiram.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25366297     DOI： 10.1038/nrurol.2014.303

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Copper signaling axis as a target for prostate cancer therapeutics.

Authors:  Rachid Safi; Erik R Nelson; Satish K Chitneni; Katherine J Franz; Daniel J George; Michael R Zalutsky; Donald P McDonnell
Journal:  Cancer Res       Date:  2014-10-15       Impact factor: 12.701
  1 in total
  1 in total

1.  Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway.

Authors:  Ye Wang; Qi-Wei Yang; Qing Yang; Tie Zhou; Min-Feng Shi; Chen-Xia Sun; Xiu-Xia Gao; Yan-Qiong Cheng; Xin-Gang Cui; Ying-Hao Sun
Journal:  Int J Nanomedicine       Date:  2017-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.